-
- Araki Ryoko
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
-
- Sugiura Mayumi
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
-
- Hoki Yuko
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
-
- Sunayama Misato
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
-
- Nakamura Miki
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
-
- Kasama Yasuji
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
-
- Abe Masumi
- Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
この論文をさがす
説明
The discovery of induced pluripotent stem cells (iPSCs) has the potential to drastically alter the future of medicine. Further, the achievement of cell lineage conversion by gene transduction is expected to make a dramatic contribution to the advancement of basic biology. Currently, various iPSC applications have been the focus of much attention due to their potential in regenerative medicine. Nevertheless, because the molecular mechanisms underlying the creation of these cells have remained elusive, confidence in their safe use in a clinical setting has remained rather shaky. In our present review, we discuss genome integrity during iPSC generation, with a particular focus on point mutations, to further address the issue of whether iPSC generation causes genetic aberrations.
収録刊行物
-
- Inflammation and Regeneration
-
Inflammation and Regeneration 35 (5), 226-232, 2015
一般社団法人 日本炎症・再生医学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680235055872
-
- NII論文ID
- 130005114592
-
- ISSN
- 18808190
- 18809693
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可